In a relatively new CGM category dominated by Dexcom and Freestyle Libre, Eversense is the only 6 month implantable system that offers long-term reliability and daily flexibility. Despite the revolutionary technology, awareness of Eversense was extremely low amongst both patients and HCPs.
Challenge the status quo of the category with real-life audience frustrations. “The CGM For Real Life” campaign explores the pain points of short-term CGMs and celebrates the everyday moments Eversense is made for.
This approach helped Eversense evolve from a niche medtech product to a true competitor, with post-launch results showing a 70% increase in conversions and 25% growth in awareness.